Clinical Trial Regulations Grow Tighter Overseas

John Carroll explains in this post on FieceBiotech that lately overseas regulators have been tightening their grasp of clinical trials around the world. Polish investigators want to know why two seniors died when they took two experimental bird flu vaccines developed by Novartis, and this is just one case of the tight regulations being put in place.

There is a growing concern that in the developing countries, the citizens are being used to test new drugs which will later be sold to more affluent markets. The Wall Street Journal estimates that roughly 40 percent of all clinical trials take place in lower-income countries.

Read the entire article in the Wall Street Journal